News

Evoq Remedies Limited submitted a certificate to the BSE Limited on October 15, 2026, confirming that Accurate Securities & Registry Private Limited processed dematerialisation requests within the stipulated time limit as per Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018, for the quarter ended September 30, 2026.

Evoq Remedies Limited informed the BSE Limited that the trading window for purchasing, selling, or dealing in the company`s equity shares will be closed for directors, promoters, designated persons, and insiders from Thursday, October 1, 2026, until 48 hours after the declaration and publication of the unaudited financial results for the half-year ended September 30, 2026.

Evoq Remedies will hold a meeting of the Board of Directors of the Company on 30 May 2026.

Evoq Remedies has revised the meeting of the Board of Directors which was scheduled to be held on 14 May 2026. The meeting will now be held on 27 May 2026.

Evoq Remedies will hold a meeting of the Board of Directors of the Company on 14 May 2026.